Literature DB >> 8361550

Morphine-induced hyperactivity in rats--a rebound effect?

B Magnus-Ellenbroek1, U Havemann-Reinecke.   

Abstract

The behavioural nature of the delayed hyperactivity induced by systemic administration of morphine was studied in rats. Different components of motility induced by morphine with or without naloxone or haloperidol at different times were analyzed by observation and quantified by an Opto-Varimex-3 Activity Meter. By this automatic recording system motility was discriminated into horizontal and two different vertical components and the total distance run by each of the rats was quantified by a computer program. Simultaneously the running pattern was recorded by a XY-plotter. By means of these recordings, three subsequent phases of behaviour could be recorded after morphine (15 mg/kg i.p.): 1. a depressed phase (akinesia) lasting 1.5-2 h, followed, 2. by an intermediate phase for 1-1.5 h, still dominated by akinesia but interrupted by sudden bursts of hyperactivity. Finally, 3. a hyperactivity phase lasted for 1.5-2 h, characterized by an equal enhancement of locomotor activity and stereotypy. After 30 mg/kg of morphine the hyperactivity was predominantly characterized by locomotor activity and stereotypy and rearing were less prominent than after the smaller dose. Naloxone (2 mg/kg i.p.) given at the beginning of the hyperactivity phase significantly antagonized rearing but not other motility parameters. However, coadministration of naloxone (2 mg/kg i.p.) simultaneously with morphine (15 mg/kg) clearly antagonized akinesia and completely prevented the development of the delayed hyperactivity. Haloperidol (0.2 mg/kg i.p.) at the beginning of the hyperactivity phase clearly antagonized all of the motility parameters seen during this phase.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361550     DOI: 10.1007/bf00166947

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal.

Authors:  L M GUNNE
Journal:  Acta Physiol Scand Suppl       Date:  1963

2.  Comparison of the effects of single doses of morphine and thebaine on body temperature, activity, and brain and heart levels of catecholamines and serotonin.

Authors:  J W SLOAN; J W BROOKS; A J EISENMAN; W R MARTIN
Journal:  Psychopharmacologia       Date:  1962-10-05

3.  Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.

Authors:  C L Broekkamp; A G Phillips; A R Cools
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

4.  Morphine-induced muscular rigidity in rats.

Authors:  P Wand; K Kuschinsky; K H Sontag
Journal:  Eur J Pharmacol       Date:  1973-11       Impact factor: 4.432

5.  Morphine catalepsy in the rat: relation to striatal dopamine metabolism.

Authors:  K Kuschinsky; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1972-07       Impact factor: 4.432

6.  Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats.

Authors:  M Winkler; U Havemann; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

7.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

8.  The role of the substantia nigra in motility of the rat. Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra.

Authors:  L Turski; U Havemann; K Kuschinsky
Journal:  Neuropharmacology       Date:  1983-09       Impact factor: 5.250

9.  An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods.

Authors:  E T Iwamoto
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Electrophysiological studies of neurons in the ventral tegmental area of Tsai.

Authors:  C Y Yim; G J Mogenson
Journal:  Brain Res       Date:  1980-01-13       Impact factor: 3.252

View more
  6 in total

1.  Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats.

Authors:  A Besson; A M Privat; A Eschalier; J Fialip
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Acute glucagon-like peptide-1 receptor agonist liraglutide prevents cue-, stress-, and drug-induced heroin-seeking in rats.

Authors:  Joaquin E Douton; Nikhil K Acharya; Brooke Stoltzfus; Dongxiao Sun; Patricia S Grigson; Jennifer E Nyland
Journal:  Behav Pharmacol       Date:  2022-06-07       Impact factor: 2.277

3.  Amphetamine and morphine may produce acute-withdrawal related hypoactivity by initially activating a common dopamine pathway.

Authors:  Wesley White; Ilsun M White
Journal:  Physiol Behav       Date:  2016-07-25

4.  Social play behavior, ultrasonic vocalizations and their modulation by morphine and amphetamine in Wistar and Sprague-Dawley rats.

Authors:  Antonia Manduca; Patrizia Campolongo; Maura Palmery; Louk J M J Vanderschuren; Vincenzo Cuomo; Viviana Trezza
Journal:  Psychopharmacology (Berl)       Date:  2013-11-13       Impact factor: 4.530

5.  Divergent profiles of fentanyl withdrawal and associated pain in mice and rats.

Authors:  Olivia Uddin; Carleigh Jenne; Megan E Fox; Keiko Arakawa; Asaf Keller; Nathan Cramer
Journal:  Pharmacol Biochem Behav       Date:  2020-12-11       Impact factor: 3.533

Review 6.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.